Life science companies are increasingly seeking to expand their global reach by bringing novel drugs, therapies and combination products to market to treat diseases both rare and widespread. Firms are under pressure to provide technologies that ensure product quality and protection, as well as efficiency and operator safety.
For antibiotic drug makers, barrier isolation is a critical tool in sterile and aseptic filling operations for various kind of dosage forms as capsules, tablets, vials for injection, and serves as containment for mostly dusty products when processing small molecule but also more biopharmaceutical therapies. In addition, these sterile mini-environments can reduce the costs for the pharmaceutical production surrounding as clean rooms, gowning and labor.
The growth in containment technology is likely to continue, as it is regarded as the most cost-effective system for maintaining the sterility assurance levels of drug products and for protecting operators and technicians from hazardous compounds. Choosing the right contamination control platform, whether under-pressure containment, RABS or isolators, is a task that requires a great deal of research into what the product needs for an effective process design. If barrier isolation technology fits the bill, it is essential to partner with a supplier who will not only provide a complete system, but also the regulatory knowledge and know-how to ensure effective therapies get to the market. With this Webinar Syntegon wants to show its expertise in different containment technologies for various antibiotic products – always perfect to individual needs.
Product managers, Analysts, Strategic planners, Marketing manager, Medical manager, Market researcher, Market Intelligence, Business Analytics
This webinar is part of our Antibiotics webinar series. Four of our sites will give you a complete overview: from liquids and powders to tablets and capsules, you will learn everything you need to know about the background and technologies related to antibiotic production in our new webinar series: https://www.syntegon.com/new-webinar-series-about-antibiotics-production